Mathilde Médical Développement acquired by Vivalto Santé
Context
Vivalto Santé acquired Mathilde Médical Développement, adding four establishments — two clinics and two radiotherapy centres — to its existing Normandie footprint. The acquisition complements Vivalto Santé's existing presence in the region through the Clinique de l'Europe in Rouen and the Hôpital Pasteur in Evreux. The deal follows a series of acquisitions completed in 2019, including the Hôpital Privé du Confluent in Nantes, the Polyclinique de l'Europe in Saint-Nazaire, and the Polyclinique du Parc in Cholet, reflecting Vivalto Santé's ongoing buy-and-build strategy across the French private hospital market.
Mathilde Médical Développement, which reported an EBITDA margin of [members only] in 2019, is valued in this transaction at an EV/EBITDA multiple of [members only], to compare with the average observed in the Healthcare & Pharma sector (14.6x in 2020).
-> Deep-dive in Healthcare & Pharma market trends
Target
Mathilde Médical Développement is a French private healthcare group based in Normandie, operating four establishments comprising two private clinics and two radiotherapy centres. The group generated annual revenues of €55 million at the time of the transaction. Its geographic positioning in Normandie makes it a highly complementary bolt-on for Vivalto Santé, which already operated the Clinique de l'Europe in Rouen and the Hôpital Pasteur in Evreux in the same region, enabling meaningful network densification and care pathway integration across the territory.
Ent. Value
€100–350M
Equity Value
[members only]
Multiples
EV / Revenue
2x–6x
EV / EBITDA
[members only]
EV / EBIT
[members only]
Historical Financials (EUR)
Other operations with Vivalto Santé
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 12/2021 | VIVALTO PARTNERS / IK PARTNERS / MACSF / ARKEA CAPITAL / BNP PARIBAS DEVELOPPEMENT | VIVALTO SANTÉ | FRANCE | Clinics / Hospitals |
Similar deals in Health Providers
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 02/2020 | CLARIANE | INICEA | FRANCE | Clinics / Hospitals |
| 02/2020 | AMUNDI PRIVATE EQUITY / SOCIETE GENERALE CAPITAL PARTENAIRES | VIVALTO VIE | FRANCE | Nursing Homes |
| 01/2020 | ARDIAN | SANTE CIE | FRANCE | Health Providers |
| 12/2019 | CIRCLE HEALTH | BMI HEALTHCARE | UNITED KINGDOM | Clinics / Hospitals |
| 07/2019 | I SQUARED CAPITAL / UI INVESTISSEMENT / BNP PARIBAS DEVELOPPEMENT | DOMIDEP | FRANCE | Nursing Homes |
| 07/2019 | NAXICAP PARTNERS / ARDIAN | EMERA | FRANCE | Nursing Homes |
| 07/2019 | TRITON PARTNERS | ALERIS | SWEDEN | Clinics / Hospitals |
| 04/2019 | COLISÉE | ARMONEA | BELGIUM | Nursing Homes |
| 03/2019 | DOMUSVI | RESIDALYA | FRANCE | Nursing Homes |
| 01/2019 | HUMANA | CORONARIA HOIVA | FINLAND | Nursing Homes |
REFERENCES
Valuation range: EV €100–350M
Revenue range: €50–100M
EV/Revenue range: 2x - 6x
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of Mathilde Médical Développement by Vivalto Santé are reserved for mynth community members. Register for free to unlock full data.
Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.
Acquirer: vivalto santé
FAQ
What transaction does this page cover?
How was the acquisition of Mathilde Médical Développement by Vivalto Santé valued, and what multiples were paid?
What was Mathilde Médical Développement’s revenue at the time of the deal?
How does the valuation of Mathilde Médical Développement compare to benchmarks in the Healthcare & Pharma sector?
What sources support the information on this transaction?
What is mynth?